FIP 2026 World Congress Programme - LSMO-02 - Dermato-pharmacy: From pharmacotherapy to integrated health management (Organised by the Skin Pharmacy Professional Committee of Chinese Medical Education Association)

LSMO-02 - Dermato-pharmacy: From pharmacotherapy to integrated health management (Organised by the Skin Pharmacy Professional Committee of Chinese Medical Education Association)

Tracks

Room 517-B

Monday, August 31, 2026

1:00 PM - 2:00 PM

Details

Organised by the Skin Pharmacy Professional Committee of Chinese Medical Education Association Programme: Prof. Quan-gang Zhu, Skin Pharmacy Professional Committee of China Medical Education Association, China and Mr Robert Moss, FIP Vice President, Netherlands Introduction: As the human body’s largest organ, the skin serves not only as a physical, chemical, microecological and immune barrier but also as an important route for drug delivery. Rising public health literacy calls for enhanced skin health management practices. Dermatopharmacy is an emerging interdisciplinary field. In 2023, the first formal professional committee in this field was established in China, integrating pharmaceutical sciences with clinical dermatology – from laboratory research and translational development to clinical practice. As an intersection of dermatology and pharmacy, it underpins the treatment of intractable skin disorders. Amid the global trend of patient-centred care, it goes beyond conventional pharmacotherapy, integrating medication intervention, health education, lifestyle guidance and interdisciplinary collaboration for integrated health management. This session brings together experts to explore latest progress, challenges and future directions of dermatopharmacy. It builds a platform for clinicians, pharmacists and healthcare workers to connect pharmacotherapy with comprehensive skin health management, aiming to optimise clinical efficacy and enhance patients’ quality of life. This session aligns with FIP’s Development Goals, particularly goal 12 (Integrated health services). Programme:

13:00 – 13:05	Introduction and Welcome Speech
	Mr Robert Moss, Vice President, International Pharmaceutical Federation (FIP), Netherlands Prof. Giovanni Pauletti, Vice President, International Pharmaceutical Federation (FIP), USA
13:05 – 13:17	Microneedle-enabled Transdermal Drug Delivery for Precision Multidisease Therapy
	Prof. Wei Wang, China Pharmaceutical University, China
13:17 – 13:29	Transdermal Delivery of Chinese Medicines: Challenges and Innovations
	Prof. Nian-ping Feng, Shanghai University of Traditional Chinese Medicine, China
13:29 – 13:41	Interdisciplinary Development of Dermatopharmacy: Bridging Research and Practice
	Prof. Quan-gang Zhu, Skin Pharmacy Professional Committee of China Medical Education Association, China
13:41 – 13:55	Panel Discussion: Optimization of Transdermal Drug Delivery in Alopecia and Skin Tumor Management: Pharmacy and Clinical Consensus
	Prof. Zhong-jian Chen, Shanghai Skin Disease Hospital, China Dr Yong-xian Lai, Shanghai Skin Disease Hospital, China Dr Xiao-feng Ding, Shanghai Skin Disease Hospital, China
13:55 – 14:00	Closing
	Prof. Quan-gang Zhu, Skin Pharmacy Professional Committee of China Medical Education Association, China Prof. Zhong-jian Chen, Shanghai Skin Disease Hospital, China

Learning objectives: 1. To demonstrate how microneedle-enabled transdermal drug delivery advances precision therapeutic strategies for diverse diseases through localized, minimally invasive and disease-oriented interventions. 2. This talk will highlight recent advances in transdermal delivery of Chinese medicines and share our latest findings. 3. 3. Helping people grasp dermatopharmacy's origin, progress, practice and future disciplinary development directions. 4. To explore transdermal delivery optimization for precise treatment of alopecia and skin tumors. Take home messages: 1. Precision therapy requires disease-specific therapeutic strategies supported by effective drug delivery. Microneedle-enabled transdermal delivery provides a versatile platform for localized and systemic treatment, facilitating safer, more effective and clinically translatable therapies across diverse diseases. 2. The Historical Evolution of Transdermal Delivery of Chinese Medicines, Emerging Transdermal Technologies, and the Development of Topical Products Derived from Chinese Medicines. 3. Dermatopharmacy is an interdisciplinary field combining pharmacy and dermatology. It covers full-chain skin drug research & patient care, solves clinical medication challenges and supports precision skin health management. 4. Transdermal delivery solves key drawbacks of traditional treatments for alopecia and skin tumors. Integrating clinical dermatology with dermatopharmacy enables safer, precise individualized skin therapy.